Page last updated: 2024-11-08

oxazepam glucuronide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

oxazepam glucuronide: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID160870
CHEBI ID168654
MeSH IDM0086459

Synonyms (17)

Synonym
beta-d-glucopyranosiduronic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1h-1,4-benzodiazepin-3-yl
6801-81-6
(2s,3s,4s,5r,6s)-6-[(7-chloro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
CHEBI:168654
oxazepam glucuronide
unii-26ik2c76no
glucopyranosiduronic aid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1h-1,4-benzodiazepin-3-yl, beta-d-
26ik2c76no ,
.beta.-d-glucopyranosiduronic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1h-1,4-benzodiazepin-3-yl
(2s,3s,4s,5r,6s)-6-[(7-chloro-2-hydroxy-5-phenyl-3h-1,4-benzodiazepin-3-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
(2s,3s,4s,5r,6s)-6-((z)-7-chloro-2-oxo-5-phenyl-2,3-dihydro-1h-benzo[e][1,4]diazepin-3-yloxy)-3,4,5-trihydroxytetrahydro-2h-pyran-2-carboxylic acid
Q27254098
oxazepam glucuronide solution
DTXSID40951163
7-chloro-2-hydroxy-5-phenyl-3h-1,4-benzodiazepin-3-yl hexopyranosiduronic acid
28472-99-3
DTXSID701028080

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The AUC of oxazepam glucuronide significantly increased from 4771 +/- 227 ng ml-1 h to 8116 +/- 644 ng ml-1 h and its elimination half-life increased from 10."( The influence of diflunisal on the pharmacokinetics of oxazepam.
de Schepper, PJ; Tjandramaga, TB; van Hecken, AM; Verbesselt, R, 1985
)
0.65

Bioavailability

ExcerptReferenceRelevance
" Absorption was almost complete, with a bioavailability of 92."( Bioavailability and pharmacokinetics of oxazepam.
Andreasen, F; Andreasen, PB; Døssing, M; Loft, S; Olesen, KL; Sonne, J; Victor, M; Vollmer-Larsen, A, 1988
)
0.27
" It was a prerequisite to establish the bioavailability of oxazepam prior to succeeding studies on the oral disposition of the drug."( Factors and conditions affecting the glucuronidation of oxazepam.
Sonne, J, 1993
)
0.29

Dosage Studied

ExcerptRelevanceReference
"Biological samples were collected from eight male subjects after ingestion of 15 or 30 mg oxazepam on separate dosing occasions with an interval of 7 days."( The concentration of oxazepam and oxazepam glucuronide in oral fluid, blood and serum after controlled administration of 15 and 30 mg oxazepam.
de Gier, JJ; Dijkhuizen, A; Egberts, AC; Hofman, BJ; Lusthof, KJ; Smink, BE; Uges, DR, 2008
)
0.63
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
glucosiduronic acidAny substance produced by linking glucuronic acid to another substance via a glycosidic bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (35.71)18.7374
1990's3 (21.43)18.2507
2000's3 (21.43)29.6817
2010's3 (21.43)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.39

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.39 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.44 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.39)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]